Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment

被引:3
|
作者
Dakhlaoui, Imen [1 ,2 ]
Bernard, Paul J. [1 ]
Pietrzak, Diana [3 ]
Simakov, Alexey [4 ]
Maj, Maciej [3 ]
Refouvelet, Bernard [1 ]
Beduneau, Arnaud [4 ]
Cornu, Raphael [4 ]
Jozwiak, Krzysztof [3 ]
Chabchoub, Fakher [2 ]
Iriepa, Isabel [5 ]
Martin, Helene [4 ]
Marco-Contelles, Jose [6 ]
Ismaili, Lhassane [1 ]
机构
[1] Univ Franche Comte, Lab LINC, Pole Chim Med, UR 481, F-25000 Besancon, France
[2] Univ Sfax, Fac Sci Sfax, Lab Appl Chem, Heterocycles Lipids & Polymers, BP 802, Sfax 3000, Tunisia
[3] Med Univ Lublin, Dept Biopharm, Ul W Chodzki 4a, PL-20093 Lublin, Poland
[4] Univ Franche Comte, PEP EA4267, F-25000 Besancon, France
[5] Univ Alcala, Dept Organ Chem & Inorgan Chem, Km 33 6, Alcala De Henares 28871, Barcelona, Spain
[6] CSIC, Lab Med Chem IQOG, C-Juan Cierva 3, Madrid 28006, Spain
关键词
calcium channel antagonism; cholinesterase inhibition; Hantzsch reaction; multitarget directed ligands; Nrf2; OXIDATIVE STRESS; THERAPEUTIC TARGET; MELATONIN; NRF2; ANTIOXIDANT; INHIBITORS; PATHWAY; BUTYRYLCHOLINESTERASE; INFLAMMATION; HYPOTHESIS;
D O I
10.3390/ijms24119742
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is a multifactorial neurodegenerative disease that has a heavy social and economic impact on all societies and for which there is still no cure. Multitarget-directed ligands (MTDLs) seem to be a promising therapeutic strategy for finding an effective treatment for this disease. For this purpose, new MTDLs were designed and synthesized in three steps by simple and cost-efficient procedures targeting calcium channel blockade, cholinesterase inhibition, and antioxidant activity. The biological and physicochemical results collected in this study allowed us the identification two sulfonamide-dihydropyridine hybrids showing simultaneous cholinesterase inhibition, calcium channel blockade, antioxidant capacity and Nrf2-ARE activating effect, that deserve to be further investigated for AD therapy.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Multicomponent Reactions for Multitargeted Compounds for Alzheimer's Disease
    Ismaili, Lhassane
    Carreiras, Maria do Carmo
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (31) : 3319 - 3327
  • [2] New Tacrine Hybrids with Natural-Based Cysteine Derivatives as Multitargeted Drugs for Potential Treatment of Alzheimer's Disease
    Keri, Rangappa S.
    Quintanova, Catarina
    Chaves, Silvia
    Silva, Diana F.
    Cardoso, Sandra M.
    Santos, M. Amelia
    CHEMICAL BIOLOGY & DRUG DESIGN, 2016, 87 (01) : 101 - 111
  • [3] New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease
    Bon, Leo
    Banas, Angelika
    Dias, Ines
    Melo-Marques, Ines
    Cardoso, Sandra M.
    Chaves, Silvia
    Santos, M. Amelia
    PHARMACEUTICS, 2024, 16 (02)
  • [4] Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease
    Hafez, Donia E.
    Dubiel, Mariam
    La Spada, Gabriella
    Catto, Marco
    Reiner-Link, David
    Syu, Yu-Ting
    Abdel-Halim, Mohammad
    Hwang, Tsong-Long
    Stark, Holger
    Abadi, Ashraf H.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01)
  • [5] Development of coumarin-benzofuran hybrids as versatile multitargeted compounds for the treatment of Alzheimer's Disease
    Hiremathad, Asha
    Chand, Karam
    Keri, Rangappa S.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 92 (02) : 1497 - 1503
  • [6] Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer's disease
    Dias, Kris Simone T.
    de Paula, Cynthia T.
    dos Santos, Thiago
    Souza, Isis N. O.
    Boni, Marina S.
    Guimaraes, Marcos J. R.
    da Silva, Fernanda M. R.
    Castro, Newton G.
    Neves, Gilda A.
    Veloso, Clarice C.
    Coelho, Marcio M.
    de Melo, Ivo Souza F.
    Giusti, Fabiana C. V.
    Giusti-Paiva, Alexandre
    da Silva, Marcelo L.
    Dardenne, Laurent E.
    Guedes, Isabella A.
    Pruccoli, Letizia
    Morroni, Fabiana
    Tarozzi, Andrea
    Viegas, Claudio, Jr.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 130 : 440 - 457
  • [7] Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease
    Choubey, Priyanka Kumari
    Tripathi, Avanish
    Sharma, Piyoosh
    Shrivastava, Sushant Kumar
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (22)
  • [8] Novel Donepezil-Arylsulfonamide Hybrids as Multitarget-Directed Ligands for Potential Treatment of Alzheimer's Disease
    Queda, Fausto
    Calo, Sonia
    Gwizdala, Karolina
    Magalhaes, Joao D.
    Cardoso, Sandra M.
    Chaves, Silvia
    Piemontese, Luca
    Amelia Santos, M.
    MOLECULES, 2021, 26 (06):
  • [9] Exploring the therapeutic potential of steroidal alkaloids in managing Alzheimer's disease
    Pandey, Pratima P.
    Kumar, Maushmi S.
    STEROIDS, 2024, 209
  • [10] Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease
    Chalupova, Katarina
    Korabecny, Jan
    Bartolini, Manuela
    Monti, Barbara
    Lamba, Doriano
    Caliandro, Rosanna
    Pesaresi, Alessandro
    Brazzolotto, Xavier
    Gastellier, Anne-Julie
    Nachon, Florian
    Pejchal, Jaroslav
    Jarosova, Michaela
    Hepnarova, Vendula
    Jun, Daniel
    Hrabinova, Martina
    Dolezal, Rafael
    Karasova, Jana Zdarova
    Mzik, Martin
    Kristofikova, Zdena
    Misik, Jan
    Muckova, Lubica
    Jost, Petr
    Soukup, Ondrej
    Benkova, Marketa
    Setnicka, Vladimir
    Habartova, Lucie
    Chvojkova, Marketa
    Kleteckova, Lenka
    Vales, Karel
    Mezeiova, Eva
    Uliassi, Elisa
    Valis, Martin
    Nepovimova, Eugenie
    Bolognesi, Maria Laura
    Kuca, Kamil
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 168 : 491 - 514